These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Biomarkers in heart failure: the past, current and future. Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637 [TBL] [Abstract][Full Text] [Related]
26. Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes. Haller PM; Beer BN; Tonkin AM; Blankenberg S; Neumann JT Clin Chem; 2021 Jan; 67(1):96-106. PubMed ID: 33225348 [TBL] [Abstract][Full Text] [Related]
27. Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers. Lippi G; Cervellin G Crit Rev Clin Lab Sci; 2014 Feb; 51(1):13-29. PubMed ID: 24410541 [TBL] [Abstract][Full Text] [Related]
28. [Modern therapy of cardiac insufficiency]. Stojsić D; Jelkić N Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395 [TBL] [Abstract][Full Text] [Related]
29. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population. Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133 [TBL] [Abstract][Full Text] [Related]
30. The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians? Perrone MA; Zaninotto M; Masotti S; Musetti V; Padoan A; Prontera C; Plebani M; Passino C; Romeo F; Bernardini S; Clerico A J Cardiovasc Med (Hagerstown); 2020 Dec; 21(12):953-963. PubMed ID: 33156589 [TBL] [Abstract][Full Text] [Related]
31. New Biomarkers and Their Potential Role in Heart Failure Treatment Optimisation-An African Perspective. Badianyama M; Mpanya D; Adamu U; Sigauke F; Nel S; Tsabedze N J Cardiovasc Dev Dis; 2022 Oct; 9(10):. PubMed ID: 36286287 [TBL] [Abstract][Full Text] [Related]